

<h3>Bibliografía</h3>

    <ol>
        <li>Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.</li>
        <li>Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Coagulation in Liver Disease Group. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 2008;6:2-9.</li>
        <li>Roberts LN, Patel RK, Arya R. Hepatology. In: Key NS, Makris M, Lillicrap D, editors. Practical Haemostasis and Thrombosis. D. Chichester, West Sussex; Hoboken, NJ : John Wiley & Sons Inc.; 2017. p. 329-39.</li>
        <li>Martín-Llahí M, Albillos A, Bañares R,  Berzigotti A, García-Criado MÁ, Genescà J, et al. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterol Hepatol 2017;40:538-80.</li>
        <li>Narayanan KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Eng J Med 2004;350:578-85.</li>
        <li>Primigani M, Barosi G, Bergamaschi G,  Gianelli U, Fabris F, Reati R, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44(6):1528-34.</li>
        <li>Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 2006;5:55-61.</li>
        <li>Regina S, Herault O, D’Iteroche L, D’Alteroche L, Binet C, Gruel Y, et al. The JAK2 mutation V617F is specifically associated with idiopathic splanchnic vein thrombosis. J Thromb Haemost 2007;5:859-61.</li>
        <li>Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010;116:878-85.</li>
        <li>Starzl TE, Demertris A, van Thiel DH. Liver transplantation. N Engl J Med 1989;321:1014-22, 1092-99.</li>
        <li>Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee, JW Andriulli A, et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Eng J Med 2012;367:716-24.</li>
    </ol>